Table 1.
Risk of PKDL development in past treated VL patients, life table analysis over time.
Figure 1.
Recruitment and outcome of PKDL screening survey.
Flow chart of study population: from number of patients screened to number of PKDL cases identified.
Figure 2.
Risk of PKDL in three VL-treatment groups, Kaplan-Meier survival analysis.
Kaplan-Meier survival analysis for three types of VL treatment.
Table 2.
Risk factors for PKDL development in past treated VL patients, exact logistic regression.